MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing
Aberrant alternative splicing has been shown to contribute to the tumorigenic processes. Here, the authors show that MTR4 is overexpressed in hepatocellular carcinoma and has a role in tumorigenesis through the modulation of the splicing of glycolytic genes PKM2 and GLUT1.
Saved in:
Main Authors: | Lili Yu, Jinchul Kim, Lei Jiang, Bingbing Feng, Yue Ying, Kai-yuan Ji, Qingshuang Tang, Wancheng Chen, Taoyi Mai, Wenlong Dou, Jianlong Zhou, Le-yang Xiang, Yang-fan He, Dinghua Yang, Qingjiao Li, Xuemei Fu, Yang Xu |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/d6f7056973d7420fa80b0b12ab8c2f6e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of prognostic alternative splicing events in sarcoma
by: Hongshuai Li, et al.
Published: (2021) -
Alternative splicing regulates distinct subcellular localization of Epithelial splicing regulatory protein 1 (Esrp1) isoforms
by: Yueqin Yang, et al.
Published: (2017) -
Alternative splicing level related to intron size and organism complexity
by: Pengcheng Yang, et al.
Published: (2021) -
Alternative splicing acts as an independent prognosticator in ovarian carcinoma
by: Yan Ouyang, et al.
Published: (2021) -
Alternative Splicing in Apicomplexan Parasites
by: Lee M. Yeoh, et al.
Published: (2019)